MedTrace Logo

A Trial of Remimazolam for Intraoperative Sedation in Pediatric and Adolescent Patients

NCT07036419 · Status: RECRUITING · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2026-02-18

No results posted yet for this study

Summary

The study is being conducted to evaluate the efficacy and safety of Remimazolam for intraoperative sedation in pediatric and adolescent patients.

Conditions

  • Operative Sedation of Pediatric
  • Operative Sedation of Adolescent Patients

Interventions

DRUG

Remimazolam Tosilate for injection

Remimazolam Tosilate for injection.

DRUG

Propofol Injection

Propofol injection.

Sponsors & Collaborators

  • Jiangsu HengRui Medicine Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
3 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-10
Primary Completion
2026-05-31
Completion
2026-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07036419 on ClinicalTrials.gov